Accessing active fragments for drug discovery utilising nitroreductase biocatalysis

Sebastian Cosgrove,Anja Winter,Jóhannes Reynisson,Lauren Holder,Eda Yuce,Gabriel Oriomah,Aimee Jenkins
DOI: https://doi.org/10.26434/chemrxiv-2024-v4hfn
2024-03-12
Abstract:Biocatalysis has played a limited role in the early stages of drug discovery. This is often attributed to the limited substrate scope of enzymes not affording access to vast areas of novel chemical space. Here, we have shown a promiscuous nitroreductase enzyme (NR-55) can be used to produce a panel of functionalised anilines from a diverse panel of aryl nitro starting materials. After screening on analytical scale, we show that sixteen substrates could be scaled to 1 mmol scale, with several poly-functional anilines afforded with ease under the standard conditions. The aniline products were also screened for activity against several cell line of interest, with modest activity observed for one compound. This study demonstrates the potential for nitroreductase biocatalysis to provide access to functional fragments under benign conditions.
Chemistry
What problem does this paper attempt to address?
The paper attempts to address the issue of generating active fragments through biocatalysis in the early stages of drug discovery. Specifically, the researchers demonstrate how to use a multifunctional nitroreductase (NR-55) to convert various aromatic nitro compounds into functionalized aniline derivatives under mild conditions. These aniline derivatives can serve as important intermediates in the drug discovery process, thereby entering new chemical space. Additionally, the study explores the biological activity of these products on several cell lines and validates their potential antibacterial and cytotoxic properties. Through this approach, the paper aims to showcase the potential of biocatalysis in drug discovery, particularly in fragment-based drug discovery (FBDD). This not only provides new synthetic pathways but also optimizes existing methods, enhancing both cost-effectiveness and efficiency.